Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 126, Issue -, Pages 31-38
Publisher
Elsevier BV
Online
2022-11-11
DOI
10.1016/j.ijid.2022.11.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
- (2022) Lamprini Veneti et al. Eurosurveillance
- Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups
- (2022) Heather J Whitaker et al. JOURNAL OF INFECTION
- Homologous and Heterologous Covid-19 Booster Vaccinations
- (2022) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans
- (2022) Florian B. Mayr et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Jill M. Ferdinands et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
- (2022) Jing Lian Suah et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Decreased severity of the Omicron variant of concern: further evidence from Italy
- (2022) Fabio Divino et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
- (2022) Peter Bager et al. LANCET INFECTIOUS DISEASES
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
- (2022) Emma K. Accorsi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: Hong Kong reports world’s highest death rate as zero covid strategy fails
- (2022) Luke Taylor BMJ-British Medical Journal
- Expert review on global real-world vaccine effectiveness against SARS-CoV-2
- (2022) Sunate Chuenkitmongkol et al. Expert Review of Vaccines
- Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
- (2022) Tarun Bhatnagar et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
- (2021) Sam Moore et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- The Combined Effect of Vaccination and Nonpharmaceutical Public Health Interventions—Ending the COVID-19 Pandemic
- (2021) Alexander Doroshenko JAMA Network Open
- COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
- (2021) Utkarsh Agrawal et al. Lancet Respiratory Medicine
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now